Clinical trials: White Matter Injury

Periventricular Leukomalacia, White Matter Disease

Cell-Based Therapy for White Matter Repair in Periventricular Leukomalacia

• Withdrawn
• Age: All ages
• Early Phase 1

The goal of this study is to explore a new treatment that may help repair brain damage in individuals with periventricular leukomalacia (PVL), a condition that affects white matter in the brain.

Conditions

Periventricular Leukomalacia, White Matter Disease, Hypoxic-Ischemic Encephalopathy, Demyelinating Diseases

Trial name

NCT06985303

Testing

Investigational Combination Product

Sponsor

MGAM LLC